You are here:

MS in the media - 21 April 2017

Published on

14 - 21 April 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Genes and MS risk

Canadian researchers have found a rare double gene mutation in a family in which five people have been diagnosed with MS. The double gene greatly raises the risk of MS to about 7 in 10, compared to about 1 in 1,000 in the general population.

Source: Medical Xpress

MS Trust link: Risk of getting MS

Tecfidera and NEDA

Further analysis of trial results found that more people taking Tecfidera (dimethyl fumarate) achieved no evidence of disease activity (NEDA) - defined as no relapses, no increase in disability over 12 weeks as measured by EDSS, and no new lesions.  About one in four of the people on Tecfidera showed no activity compared to about one in eight in a placebo group

Source: Neurology Advisor

MS Trust link: MS Decisions - a guide to the disease modifying drugs

Early warnings of future MS diagnosis revealed in medical history

People with MS can show signs of something wrong five years before their first episode of neurological symptoms, according to a new analysis of Canadian health records.

Source: Eurekalert

MS Trust link: Early signs of MS

Print this page